Xeris Pharmaceuticals Obtains $4,000,002 New Funding

  • Feed Type
  • Date
    1/3/2017
  • Company Name
    Xeris Pharmaceuticals
  • Mailing Address
    3208 Red River Street Austin, TX 78705 USA
  • Company Description
    Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology.
  • Website
    http://www.xerispharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,000,002
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 48 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy